Brian Liau

Title: Brian Liau: Innovator in Monoclonal Antibody Analysis

Introduction

Brian Liau is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the analysis of monoclonal antibodies. With a total of 2 patents, Liau's work focuses on enhancing the sensitivity and specificity of antibody aggregation estimation.

Latest Patents

Liau's latest patents include a high-throughput, fluorescence-based assay for rapid, semi-quantitative estimation of high-molecular weight aggregation in monoclonal antibody samples. This innovative method utilizes disodium 3,3'-{[(E)-1,2-diphenyl-1,2-ethenediyl]bis(4,1-phenyleneoxy)}di (1-propanesulfonate) dye to achieve superior sensitivity and specificity. Additionally, he has developed methods and systems for imaging precision ellipsometry of a sample. This method involves shining a source of linearly polarized light on the sample's surface and converting the polarization of the reflected light into linear polarization suitable for a polarization modulator. The process includes synchronizing image acquisition with the oscillations of the polarization modulator to generate difference images that reflect the polarization rotation of the light.

Career Highlights

Throughout his career, Brian Liau has worked with prominent organizations such as Agilent Technologies, Inc. and the Agency for Science, Technology and Research. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in his field.

Collaborations

Liau has collaborated with notable professionals, including Ravindra Gudihal and Nikolai Leopoldovich Yakovlev. These collaborations have further enriched his research and development efforts.

Conclusion

Brian Liau stands out as an innovative inventor in the biotechnology sector, with a focus on monoclonal antibody analysis. His patents reflect his commitment to advancing scientific understanding and improving methodologies in this critical area.